drugset / Trial / NCT00134147

A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

NCT00134147

Phase 3 Completed 1100 enrolled Pfizer Sanofi · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

Timeline

Start
2005-04
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Inhaled